{"nct_id":"NCT01023880","title":"Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy","status":"TERMINATED","status_verified_date":"2016-03","start_date":"2010-01","start_date_type":null,"primary_completion_date":"2012-11","primary_completion_date_type":"ACTUAL","completion_date":"2013-01","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TEVA"]}